Affordable Access

deepdyve-link
Publisher Website

Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development.

Authors
  • T, Burns
  • T, Itoh
  • H, Shen
  • E, Lee
  • J, Sohn
  • D, Pleasure
  • F, Guo
  • Y, Maeda
  • Em, Ko
  • M, Delgado
  • M, Horiuchi
  • Athena Soulika
  • L, Miers
Type
Published Article
Journal
Journal of Neuroscience
Publisher
Society for Neuroscience
Volume
32
Issue
2
Pages
639–639
Identifiers
DOI: 10.1523/JNEUROSCI.4073-11.2012
Source
Soulika Lab - UC Davis dermatology-ucdavis
License
Unknown

Abstract

Pharmacological studies have suggested that oligodendroglial NMDA glutamate receptors (NMDARs) mediate white matter injury in a variety of CNS diseases, including multiple sclerosis (MS). We tested this hypothesis in experimental autoimmune encephalomyelitis (EAE), a model of human MS, by timed conditional disruption of oligodendroglial NR1, an essential subunit of functional NMDARs, using an inducible proteolipid protein (Plp) promoter-driven Cre-loxP recombination system. We found that selective ablation of oligodendroglial NR1 did not alter the clinical severity of EAE elicited in C57BL/6 mice by immunization with myelin oligodendrocyte glycoprotein peptide 35-55 (MOG-peptide), nor were there significant differences between the oligodendroglial NR1 KO and non-KO mice in numbers of axons lost in spinal cord dorsal funiculi or severity of spinal cord demyelination. Similarly, constitutive deletion of NR3A, a modulatory subunit of oligodendroglial NMDARs, did not alter the course of MOG-peptide EAE. Furthermore, conditional and constitutive ablation of NR1 in neonatal oligodendrocyte progenitor cells did not interrupt their normal maturation and differentiation. Collectively, our data suggest that oligodendroglial lineage NMDARs are neither required for timely postnatal development of the oligodendroglial lineage, nor significant participants in the pathophysiology of MOG-peptide EAE.

Report this publication

Statistics

Seen <100 times